Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Summary What is already known about this topic? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). What is added by this report? In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. What are the implications for public health practice? The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy.

Cite

CITATION STYLE

APA

Wang, L., Wang, S., Zhang, X., & Jia, Z. (2022). Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021. China CDC Weekly, 4(5), 79–82. https://doi.org/10.46234/ccdcw2022.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free